FDA supports mRNA vaccines but taxpayers should not bear the cost, commissioner says

Commissioner Marty Makary defended his agency's position and record on mRNA vaccines, days after it changed course and agreed ...
BioSpace

FDA’s Makary Backs mRNA Vaccines but Says Companies ‘Can Fund Their Own Research’

In August last year, the Health Department cut around $500 million in mRNA research funding, with Health Secretary Robert F.
WFMZ-TV

New Trial Shows Pfizer’s mRNA Flu Shot Beats Traditional Flu Vaccine

Pfizer’s mRNA flu shot prevented more flu-like illness than a standard vaccine More than 18,000 adults took part in the study Side effects were mild and went away quickly FRIDAY, Nov. 21, 2025 ...
Scientific American

FDA won’t consider a new mRNA vaccine for flu despite the technology’s life-saving promise

America’s drug safety agency declined to review a next-gen flu vaccine that uses the same tech as the coronavirus shots ...
Clinical Trials Arena

FDA reversal on mRNA-1010 could transform the seasonal influenza vaccines market

Moderna has announced that the FDA will initiate the review of its seasonal influenza vaccine candidate, mRNA-1010.

FDA refuses to review Moderna’s application for mRNA flu vaccine, company says

The US Food and Drug Administration has refused to accept an application from Moderna to review its first mRNA seasonal flu vaccine, the company said Tuesday, in another setback for the technology ...
The Grand Junction Daily Sentinel

New Trial Shows Pfizer’s mRNA Flu Shot Beats Traditional Flu Vaccine

FRIDAY, Nov. 21, 2025 (HealthDay News) — Pfizer’s mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported. The results, published Nov. 19 in The New ...